LAUNCH DAY: Elysium’s biggest milestone since 2015
The Elysium Longevity Institute opens today.
Elysium Health launches The Elysium Longevity Institute, a physician-led platform for personalized longevity medicine. The institute offers comprehensive programs spanning cellular health, peptides, and metabolic and weight management. It provides trusted guidance and access to novel advancements in longevity science, led by a team of medical experts.
Read this email as text
for screen readers, or when images don't load
Elysium | The future of longevity starts here and now Introducing our physician-led platform for personalized longevity medicine. | Explore TELI
Dear Elysium Community,
Today, I'm proud to share the most significant milestone in Elysium's history since our launch in 2015: The Elysium Longevity Institute (TELI) is officially open.
When we founded Elysium, our mission was clear: bring leading-edge longevity science out of the world’s best labs and into people's lives. Over the past decade, we've helped define new categories—from NAD+ to senolytics to biological age—and supported more than 25 clinical studies in pursuit of healthier aging.
Today, people are looking for trusted guidance. They want to understand which interventions are right for them, access novel advancements in longevity science, and bring everything together in a personalized protocol developed with expert clinical guidance.
That's why we built TELI.
Spanning cellular health, peptides, and metabolic and weight management, the Institute brings together personalized, physician-led care, uncompromising quality and safety standards, and a commitment to advancing clinical research in one comprehensive program. TELI is led by Omar Baker, M.D., F.A.A.P., Chief Medical Officer, and Leonard Guarente, Ph.D., Elysium Chief Scientist and Novartis Professor of Biology at MIT.
This is the future of longevity medicine—and we’re gratified to once again be at the forefront.
Welcome to The Elysium Longevity Institute.
In good health,
Email headers
sender, ESP fingerprints, unsubscribe and auth headers
As received, minus the delivery side: the archive's own addresses appear as [recipient], relay hops and signatures are left out, and unsubscribe links are trimmed to their host.
- Received-SPF
- pass ([receiver]: domain of [email protected] designates 159.112.241.119 as permitted sender) receiver=[receiver]; client-ip=159.112.241.119; envelope-from="[email protected]"; helo=v5119.v5c4dda55.use4.send.mailgun.net;
- Authentication-Results
- [receiver]; dkim=pass header.d=cio156609.elysiumhealthrx.com header.s=cio header.b=ZuBLUSS0; dmarc=pass header.from=elysiumhealthrx.com policy.dmarc=none; spf=none ([receiver]: no SPF records found for [email protected]) smtp.helo=v5119.v5c4dda55.use4.send.mailgun.net; spf=pass ([receiver]: domain of [email protected] designates 159.112.241.119 as permitted sender) [email protected]; arc=none smtp.remote-ip=159.112.241.119
- X-Mailgun-Sid
- WyIxODg5MCIsImVseXNpdW1AaW5ib3hhcmNoaXZlLm9yZyIsImFlOWU2ZGMiXQ==
- X-Mailgun-Sending-Ip
- 159.112.241.119
- Date
- Tue, 08 Sep 2026 20:30:07 +0000
- Mime-Version
- 1.0
- Content-Type
- multipart/alternative; boundary="8c0ac7aac0161a4d993f5f3b14b1731850058c8a6a8544d60d6edb03cc4d"
- Subject
- LAUNCH DAY: Elysium’s biggest milestone since 2015
- From
- TELI by Elysium <[email protected]>
- X-Mailgun-Dkim
- true
- X-Mailgun-Native-Send
- true
- X-Mailgun-Track-Clicks
- false
- X-Mailgun-Track-Opens
- false
- X-Mailer
- Customer.io (dgSi0w0DAMLSBsHSBgGggraglobKaKtrZWZZSkQ=; +https://whatis.customeriomail.com)
- X-Report-Abuse-To
- [email protected]
- Reply-To
- TELI by Elysium <[email protected]>
- List-Unsubscribe
- <mailto:…@unsubscribe2.customer.io>, <https://e.elysiumhealthrx.com/…>
- List-Unsubscribe-Post
- List-Unsubscribe=One-Click
- X-Mailgun-Variables
- {"email_id": "dgSi0w0DAMLSBsHSBgGggraglobKaKtrZWZZSkQ="}
- Message-Id
- <[email protected]>
Archived for reference and commentary. Elysium Health, its logos and content are the property of their respective owners; Inbox Archive claims no affiliation and has disabled all links. If you own this content and would like it removed, get in touch.
Similar campaigns from other brands
Different brands running the same play. Compare any of them side by side.
